Amyloidosis: Difference between revisions

(Text replacement - "* " to "*")
Tag: mobile edit
No edit summary
Line 12: Line 12:
*Restrictive [[cardiomyopathy]]
*Restrictive [[cardiomyopathy]]
*Sensory and autonomic neuropathies (no CNS involvement)
*Sensory and autonomic neuropathies (no CNS involvement)
**Sensory neuropathy: symmetrical pattern, progresses distal to proximal
**[[numbness|Sensory neuropathy]]: symmetrical pattern, progresses distal to proximal
**Autonomic neuropathy: orthostatic hypotension or nonspecific GI symptoms
**Autonomic neuropathy: orthostatic [[hypotension]] or nonspecific GI symptoms
*Hepatomegaly, elevated serum AST and AlkPhos
*[[Hepatomegaly]], elevated serum AST and AlkPhos
*[[Diabetes]] secondary to pancreatic infiltration
*[[Diabetes]] secondary to pancreatic infiltration
*[[Macroglossia]]
*[[Macroglossia]]
Line 25: Line 25:


==Management==
==Management==
*Varies depending on underlying etiology and organ systems involved


==Disposition==
==Disposition==

Revision as of 22:09, 1 October 2019

Background

  • Accumulation of proteins (amyloid fibrils) in tissues
  • Heart and kidneys most commonly affected organs
  • Causes:
    • Primary amyloidosis, hereditary amyloidosis
    • Secondary (due to systemic inflammatory condition)
    • ESRD-associated (caused by β2-microglobulin amyloids, not filtered out by dialysis membranes))
    • Senile amyloidosis (causes cardiac amyloid)

Clinical Features

Differential Diagnosis

Evaluation

  • Evaluate for other causes of symptoms
  • Diagnosis via fat pad biopsy: apple-green birefringence with Congo red stain

Management

  • Varies depending on underlying etiology and organ systems involved

Disposition

See Also

External Links

References